Immunogenicity and Safety after Booster Vaccination of Diphtheria, Tetanus, and Acellular Pertussis in Young Adults: an Open Randomized Controlled Trial in Japan

Epidemic Pertussis in 2012 — The Resurgence of a Vaccine-Preventable Disease

(2012) James D. Cherry   NEW ENGLAND JOURNAL OF MEDICINE

Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children

(2012) Nicola P. Klein et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prevalence and Genetic Characterization of Pertactin-Deficient Bordetella pertussis in Japan

(2012) Nao Otsuka et al.   PLoS One

Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): A review of evidences and recommendations

(2012) Angela Bechini et al.   VACCINE

Pertussis outbreaks and pertussis vaccines: New insights, new concerns, new recommendations?

(2012) Gregory A. Poland   VACCINE

Outbreak of Pertussis in a University Laboratory

(2011) Naoyuki Miyashita et al.   INTERNAL MEDICINE

Rationale for pertussis booster vaccination throughout life in Europe

(2011) Fred Zepp et al.   LANCET INFECTIOUS DISEASES

Decennial Administration of a Reduced Antigen Content Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine in Young Adults

(2010) Jussi Mertsola et al.   CLINICAL INFECTIOUS DISEASES

The Present and Future Control of Pertussis

(2010) James D. Cherry   CLINICAL INFECTIOUS DISEASES

Safe and effective booster immunization using DTaP in teenagers

(2010) Kenji Okada et al.   VACCINE

IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: Effect of vaccine antigen content

(2009) Lotte H. Hendrikx et al.   VACCINE

Antigenic variation in Bordetella pertussis isolates recovered from adults and children in Japan

(2008) Hyun-Ja Han et al.   VACCINE

Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19–64 years of age

(2008) Mark Blatter et al.   VACCINE